MediRX offers two primary GLP-1 medications for weight management:
Semaglutide
Semaglutide is a GLP-1 receptor agonist that helps control appetite and blood sugar levels. It is available as a weekly injectable or sublingual (under the tongue) formulation.
Tirzepatide
Tirzepatide is a dual GIP and GLP-1 receptor agonist that supports weight loss by reducing appetite and improving metabolic function. It is available as a weekly injectable.
Both medications are prescribed by our licensed providers based on your individual health history and goals.
Important: These medications are prescription only and must be approved by a licensed provider. For questions about your specific treatment, contact your prescribing provider through your patient portal.